Open-Label Tolvaptan Study in Subjects With ADPKD (TEMPO 4/4)
What is the purpose of this trial?
To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from baseline (from trial 156-04-251) in total kidney volume (TKV) and renal function.
- 18 Months and older
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Last Updated:
- Study HIC#: